Kallmann's syndrome

Kallmann's syndrome is a genetic disorder characterized by hypogonadotropic hypogonadism (a condition causing low levels of sex hormones) and anosmia (the inability to smell). It is named after the German-American physician Franz Josef Kallmann, who first described the condition in 1944.

Etiology

Kallmann's syndrome is caused by a disruption in the development of the hypothalamus, a region of the brain that controls the release of hormones from the pituitary gland. This disruption results in a deficiency of gonadotropin-releasing hormone (GnRH), which is essential for sexual development and reproduction.

Symptoms

The primary symptoms of Kallmann's syndrome are delayed or absent puberty and a reduced or absent sense of smell. Other symptoms can include cryptorchidism (undescended testicles) in males, amenorrhea (absence of menstrual periods) in females, and infertility in both sexes.

Diagnosis

Diagnosis of Kallmann's syndrome is typically based on the presence of the characteristic symptoms, particularly delayed puberty and anosmia. Additional tests may include a blood test to measure hormone levels, MRI to examine the brain and olfactory system, and genetic testing to identify any mutations associated with the condition.

Treatment

Treatment for Kallmann's syndrome primarily involves hormone replacement therapy to induce puberty and maintain normal hormone levels. In some cases, fertility treatments may be used to help individuals with the condition conceive children.

Prognosis

With appropriate treatment, individuals with Kallmann's syndrome can lead normal lives. However, they may require lifelong hormone replacement therapy and may have difficulties with fertility.

See also

• Hypogonadism
• Anosmia
• Hypothalamus
• Pituitary gland

NIH genetic and rare disease info

• NIH info on Kallmann's syndrome

Kallmann's syndrome is a rare disease.

Kallmann's syndrome Resources
Latest articles Most recent articles Ongoing trials	Wikipedia